Dibenzepin

DB13225ApprovedSmall molecule

Dibenzepin is approved for use in Europe.

Mechanism: Pharmacologically active on Histamine H1 receptor and Sodium-dependent noradrenaline transporter
Curator reviewed
Formula / weight: C₁₈H₂₁N₃O · 295.386 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyQPGGEKPRGVJKQB-UHFFFAOYSA-NSMILESCN(C)CCN1C2=CC=CC=C2N(C)C2=CC=CC=C2C1=O

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1,354Drug interactionsStructured to mechanism, not free text

1ATC codeIncluding every combination product, plus 14 drug categories

14+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dibenzepin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.